Tascenso odt and Fatigue - a phase IV clinical study of FDA data

Summary:

We study 967,646 people who take Tascenso odt (fingolimod lauryl sulfate) or have Fatigue. No report of Fatigue is found in people who take Tascenso odt.

The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.

What is Tascenso Odt?

Tascenso odt has active ingredients of fingolimod lauryl sulfate. eHealthMe is studying from 107 Tascenso odt users. Check the latest studies of Tascenso odt.

What is Fatigue?

Fatigue (feeling of tiredness) is found to be associated with 4,028 drugs and 6,382 conditions by eHealthMe. Check the latest studies of Fatigue.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

No report is found.

Do you take Tascenso odt and have Fatigue?

- Check whether Fatigue is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tascenso odt:

Tascenso odt (107 reports)

Fatigue treatments and more:

Fatigue (967,539 reports)

How severe was Fatigue and when was it recovered:

Fatigue in Tascenso odt

Expand to all the drugs that have ingredients of fingolimod lauryl sulfate:

Fatigue and drugs with ingredients of fingolimod lauryl sulfate

Browse all side effects of Tascenso odt:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Fatigue:

Fatigue

Browse all the conditions that are associated with Fatigue:

Fatigue

How the study uses the data?

The study uses data from the FDA. It is based on fingolimod lauryl sulfate (the active ingredients of Tascenso odt) and Tascenso odt (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.